Scientists develop new method to isolate 'IgA-coated' gut bacteria that are associated with a variety of diseases
Scientists at UMC Utrecht have developed a new technology to efficiently isolate a specific subset of gut bacteria from fecal ...
Neuroscience News6h
Microbial Load, Not Disease, Shapes Gut Microbiome Signatures
A new study reveals that changes in gut microbial load, influenced by factors like diet, age, and antibiotics, drive the presence of bacteria previously linked to diseases such as inflammatory bowel ...
Too Old to Operate12h
CT-P13 Effectiveness in Management of Crohn’s Disease and Ulcerative Colitis
P13, a biosimilar of infliximab, in inflammatory bowel diseases: a systematic review and meta-analysis," published in the November 2024 issue of Gastroenterology by Hu et al. Since 2015, CT-P13, a ...
Finding A Path To Clear Skin While Living With Plaque Psoriasis
One woman’s journey from receiving her diagnosis to finding a treatment that helps manage her chronic skin condition.
The Beaumont Enterprise6h
Experts warn against sitting on the toilet for more than 10 minutes
CNN also spoke with Dr. Farah Monzur, an assistant professor of medicine and director of the Inflammatory Bowel Disease ...
Q&A: Holobiont biology, a new concept for exploring how microbiome shapes evolution of visible life
Microorganisms—bacteria, viruses and other tiny life forms—may drive biological variation in visible life as much, if not ...
Le Lézard7h
Thetis Pharmaceuticals Announces Appointment of Fabio Cataldi, M.D., to Board of Managers and Scientific Advisory Board
Thetis Pharmaceuticals, LLC ("Thetis"), a pharmaceutical company developing an oral, small molecule Resolvin E1 (RvE1) drug targeting the BLT1 receptor to treat inflammatory bowel disease (IBD) and ...
Vanguard23h
Don’t spend more than 10 minutes on toilet sit, doctors warn
Dr. Farah Monzur, an assistant professor of medicine and director of the Inflammatory Bowel Disease Center at Stony Brook ...
cambridgeindependent2h
Initial ulcerative colitis patients dosed as Microbiotica’s first in-human trial commences for MB310
The first patient has been dosed in Microbiotica’s Phase 1b first-in-human trial, COMPOSER-1, of MB310.
Naija Gist - Latest7h
Sitting on the toilet for more than 10 minutes is risky - Doctors caution
What begins as a quick three-minute bathroom break often turns into 15 minutes of scrolling, reading, and posting—a familiar ...
DON’T Sit on the Toilet for More Than TEN minutes, Doctors Warn | WATCH
According to Dr. Farah Monzur from Stony Brook Medicine, people should limit toilet time to 5-10 minutes to avoid issues.
Nutrilite’s GutProtein offers gut-first solution to Malaysia’s silent health crisis
Millions of Malaysians aren’t aware that a huge list of health problems —both mental and physical — can be directly linked to the state of their gut health.